Publications
- Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer2015 | Second Faculty of Medicine
- Intensive physical activity increases peripheral blood dendritic cells2010 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- FOCUS on FOCIS: Combined chemo-immunotherapy for the treatment of hormone-refractory metastatic prostate cancer2009 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- Intense physical exercise increases peripheral blood dendritic cells subsets in elite athletes2009 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- News in immunology2023 | Second Faculty of Medicine
- Peripheral gene signatures reveal distinct cancer patient immunotypes with therapeutic implications for autologous DC-based vaccines2022 | Second Faculty of Medicine, First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Effectiveness and Durability of mRNA Vaccine-Induced SARS-CoV-2-Specific Humoral and Cellular Immunity in Severe Asthma Patients on Biological Therapy2022 | Second Faculty of Medicine
- Immunodeficiency2021 | Second Faculty of Medicine
- The WNT/beta-catenin signaling inhibitor XAV939 enhances the elimination of LNCaP and PC-3 prostate cancer cells by prostate cancer patient lymphocytes in vitro2019 | Second Faculty of Medicine
- Advances in immunotherapy in oncology2019 | Second Faculty of Medicine
Loading network view...